Craneware (LON:CRW) share price: £130 million wiped out after FY26 warning as 340B timing hits growth
Craneware plc lost about £130 million of equity value on Friday after the healthcare software group said delayed 340B drug activity and pushed-out enterprise contracts would leave full-year revenue and profit below market expectations. London markets were closed on Saturday, so the fall stands as the last traded price for the week. The stock closed at 1,082p, down 380p, or 26.0%, from Thursday’s 1,462p close. Reported volume was 2.52 million shares, equal to about 7.4% of Craneware’s AIM securities in issue. That is the sharper investor point: a near-flat earnings reset triggered heavy churn in a stock with only 34.24 million shares in issue, excluding treasury shares.